Specialty pharmaceutical company Endo Pharmaceuticals rose 13% on hopes for its pain drug, Opana.
FORBES: August's Biggest Biotech Winners
2.
But the companies focus on very different areas: Endo has stayed focused on powerful pain drugs, including its new entrant Opana, which is an extended release morphine formulation.